125 related articles for article (PubMed ID: 8133370)
1. Invasive oral aspergillosis in immunocompromised patients with leukemia.
Sugata T; Myoken Y; Kyo T; Fujihara M
J Oral Maxillofac Surg; 1994 Apr; 52(4):382-6. PubMed ID: 8133370
[TBL] [Abstract][Full Text] [Related]
2. Pathological features of invasive oral aspergillosis in patients with hematologic malignancies.
Myoken Y; Sugata T; Kyo TI; Fujihara M
J Oral Maxillofac Surg; 1996 Mar; 54(3):263-70. PubMed ID: 8600231
[TBL] [Abstract][Full Text] [Related]
3. Orofacial aspergillosis in acute leukemia.
Dreizen S; Bodey GP; McCredie KB; Keating MJ
Oral Surg Oral Med Oral Pathol; 1985 May; 59(5):499-504. PubMed ID: 3859809
[TBL] [Abstract][Full Text] [Related]
4. Primary aspergillosis affecting the tongue of a leukemic patient.
Correa ME; Soares AB; de Souza CA; Cintra ML; Jorge J; Almeida OP; Vargas PA
Oral Dis; 2003 Jan; 9(1):49-53. PubMed ID: 12617259
[TBL] [Abstract][Full Text] [Related]
5. Oral aspergillosis in compromised patients.
Sugata T; Myoken Y; Kyo T; Fujihara M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jun; 81(6):632-3. PubMed ID: 8784891
[No Abstract] [Full Text] [Related]
6. Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
Forghieri F; Rossi G; Potenza L; Morselli M; Barozzi P; Vallerini D; Messino M; Rumpianesi F; Pecorari M; Torelli G; Luppi M
Am J Hematol; 2010 Mar; 85(3):188-9. PubMed ID: 19507207
[No Abstract] [Full Text] [Related]
7. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
Oren I; Haddad N; Finkelstein R; Rowe JM
Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
[TBL] [Abstract][Full Text] [Related]
8. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients.
Conneally E; Cafferkey MT; Daly PA; Keane CT; McCann SR
Bone Marrow Transplant; 1990 Jun; 5(6):403-6. PubMed ID: 2196098
[TBL] [Abstract][Full Text] [Related]
9. Primary invasive oral aspergillosis: an updated literature review.
Fuqua TH; Sittitavornwong S; Knoll M; Said-Al-Naief N
J Oral Maxillofac Surg; 2010 Oct; 68(10):2557-63. PubMed ID: 20417591
[No Abstract] [Full Text] [Related]
10. Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.
Harari S
Drugs; 1999 Oct; 58(4):621-31. PubMed ID: 10551434
[TBL] [Abstract][Full Text] [Related]
11. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
[TBL] [Abstract][Full Text] [Related]
12. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
Klein KC; Blackwood RA
Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
[TBL] [Abstract][Full Text] [Related]
13. Oral complications associated with aspergillosis in patients with a hematologic malignancy. Presentation and treatment.
Chambers MS; Lyzak WA; Martin JW; Lyzak JS; Toth BB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 May; 79(5):559-63. PubMed ID: 7600217
[TBL] [Abstract][Full Text] [Related]
14. Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report.
Myoken Y; Sugata T; Kyo T; Fujihara M
J Oral Pathol Med; 1995 May; 24(5):237-40. PubMed ID: 7616464
[TBL] [Abstract][Full Text] [Related]
15. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.
Offner F; Krcmery V; Boogaerts M; Doyen C; Engelhard D; Ribaud P; Cordonnier C; de Pauw B; Durrant S; Marie JP; Moreau P; Guiot H; Samonis G; Sylvester R; Herbrecht R;
Antimicrob Agents Chemother; 2004 Dec; 48(12):4808-12. PubMed ID: 15561860
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
[TBL] [Abstract][Full Text] [Related]
17. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.
Gerson SL; Talbot GH; Hurwitz S; Strom BL; Lusk EJ; Cassileth PA
Ann Intern Med; 1984 Mar; 100(3):345-51. PubMed ID: 6696356
[TBL] [Abstract][Full Text] [Related]
18. Failure of amphotericin B spray to prevent aspergillosis in granulocytopenic patients.
Jorgensen CJ; Dreyfus F; Vaixeler J; Guyomard S; Massiot C; Belanger C; Brunet F; Giraud T; Dupuis-Camay P
Nouv Rev Fr Hematol (1978); 1989; 31(5):327-8. PubMed ID: 2587200
[TBL] [Abstract][Full Text] [Related]
19. Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review.
Mayer JM; Nimer L; Carroll K
Clin Infect Dis; 1992 Oct; 15(4):698-700. PubMed ID: 1420684
[TBL] [Abstract][Full Text] [Related]
20. Aspergillosis of larynx.
Rao PB
J Laryngol Otol; 1969 Apr; 83(4):377-9. PubMed ID: 5775803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
